trimethyloxamine has been researched along with Auricular Fibrillation in 13 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Few studies have examined the associations of trimethylamine-N-oxide (TMAO) and its precursors (choline, betaine, dimethylglycine, and L-carnitine) with the risk of atrial fibrillation (AF) and heart failure (HF)." | 8.02 | Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study. ( Alonso-Gómez, A; Bulló, M; Clish, C; Corella, D; Estruch, R; Fiol, M; Fitó, M; Guasch-Ferré, M; Hernández-Alonso, P; Hu, FB; Li, J; Liang, L; Martínez-González, MA; Papandreou, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Santos-Lozano, JM; Serra-Majem, L; Toledo, E, 2021) |
| "Few studies have examined the associations of trimethylamine-N-oxide (TMAO) and its precursors (choline, betaine, dimethylglycine, and L-carnitine) with the risk of atrial fibrillation (AF) and heart failure (HF)." | 4.02 | Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study. ( Alonso-Gómez, A; Bulló, M; Clish, C; Corella, D; Estruch, R; Fiol, M; Fitó, M; Guasch-Ferré, M; Hernández-Alonso, P; Hu, FB; Li, J; Liang, L; Martínez-González, MA; Papandreou, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Santos-Lozano, JM; Serra-Majem, L; Toledo, E, 2021) |
| " A dose-response meta-analysis was used to investigate the dose-response relationship between TMAO levels and the risk of AF." | 2.72 | A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation. ( Li, XD; Wang, YT; Yang, R; Yang, WT; Zhao, Q, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 8 (61.54) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, WT | 1 |
| Yang, R | 1 |
| Zhao, Q | 1 |
| Li, XD | 1 |
| Wang, YT | 1 |
| Huang, R | 1 |
| Yan, L | 1 |
| Lei, Y | 1 |
| Luo, Y | 1 |
| Zhang, Y | 2 |
| Han, X | 1 |
| Yuan, Y | 1 |
| Zhou, Y | 1 |
| Gao, Y | 1 |
| Yu, H | 1 |
| Zhang, J | 1 |
| Shi, Y | 1 |
| Duan, Y | 1 |
| Zhao, X | 1 |
| Yan, S | 1 |
| Hao, H | 1 |
| Dai, C | 1 |
| Zhao, S | 1 |
| Shi, J | 1 |
| Li, W | 1 |
| Zhang, S | 1 |
| Xu, W | 1 |
| Fang, N | 1 |
| Gong, Y | 1 |
| Li, Y | 1 |
| Jiang, WY | 1 |
| Huo, JY | 1 |
| Wang, SC | 1 |
| Cheng, YD | 1 |
| Lyu, YT | 1 |
| Jiang, ZX | 1 |
| Shan, QJ | 1 |
| Konieczny, R | 1 |
| Żurawska-Płaksej, E | 1 |
| Kaaz, K | 1 |
| Czapor-Irzabek, H | 1 |
| Bombała, W | 1 |
| Mysiak, A | 1 |
| Kuliczkowski, W | 1 |
| Melnychuk, I | 1 |
| Lizogub, VG | 1 |
| Gong, D | 1 |
| Zhang, L | 1 |
| Wang, F | 1 |
| Zhao, Z | 1 |
| Zhou, X | 2 |
| Zuo, K | 1 |
| Liu, X | 1 |
| Wang, P | 1 |
| Jiao, J | 1 |
| Han, C | 1 |
| Liu, Z | 1 |
| Yin, X | 1 |
| Li, J | 2 |
| Yang, X | 1 |
| Papandreou, C | 1 |
| Bulló, M | 1 |
| Hernández-Alonso, P | 1 |
| Ruiz-Canela, M | 1 |
| Guasch-Ferré, M | 1 |
| Toledo, E | 1 |
| Clish, C | 1 |
| Corella, D | 1 |
| Estruch, R | 1 |
| Ros, E | 1 |
| Fitó, M | 1 |
| Alonso-Gómez, A | 1 |
| Fiol, M | 1 |
| Santos-Lozano, JM | 1 |
| Serra-Majem, L | 1 |
| Liang, L | 1 |
| Martínez-González, MA | 1 |
| Hu, FB | 1 |
| Salas-Salvadó, J | 1 |
| Yu, L | 1 |
| Meng, G | 1 |
| Huang, B | 1 |
| Stavrakis, S | 1 |
| Wang, M | 2 |
| Li, X | 1 |
| Zhou, L | 1 |
| Wang, Y | 1 |
| Wang, Z | 1 |
| Deng, J | 1 |
| Po, SS | 1 |
| Jiang, H | 1 |
| Svingen, GFT | 1 |
| Zuo, H | 1 |
| Ueland, PM | 1 |
| Seifert, R | 1 |
| Løland, KH | 1 |
| Pedersen, ER | 1 |
| Schuster, PM | 1 |
| Karlsson, T | 1 |
| Tell, GS | 1 |
| Schartum-Hansen, H | 1 |
| Olset, H | 1 |
| Svenningsson, M | 1 |
| Strand, E | 1 |
| Nilsen, DW | 1 |
| Nordrehaug, JE | 1 |
| Dhar, I | 1 |
| Nygård, O | 1 |
| Liang, Z | 1 |
| Dong, Z | 1 |
| Guo, M | 1 |
| Shen, Z | 1 |
| Yin, D | 1 |
| Hu, S | 1 |
| Hai, X | 1 |
| Lin, T | 1 |
| Li, K | 1 |
| He, W | 1 |
| Chen, L | 1 |
| Wang, T | 1 |
| Wang, N | 1 |
2 reviews available for trimethyloxamine and Auricular Fibrillation
| Article | Year |
|---|---|
A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation.
Topics: Atrial Fibrillation; Gastrointestinal Microbiome; Humans; Incidence; Methylamines; Risk Factors | 2021 |
The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies.
Topics: Atrial Fibrillation; Gastrointestinal Microbiome; Humans; Metabolic Networks and Pathways; Methylami | 2021 |
1 trial available for trimethyloxamine and Auricular Fibrillation
| Article | Year |
|---|---|
Trimethylamine N-oxide as a risk marker for ischemic stroke in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Biomarkers; Brain Ischemia; Female; Humans; Male; Methylamines; Middle Ag | 2019 |
10 other studies available for trimethyloxamine and Auricular Fibrillation
| Article | Year |
|---|---|
Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis.
Topics: Adolescent; Akkermansia; Animals; Atrial Fibrillation; Cross-Sectional Studies; Humans; Methylamines | 2022 |
Trimethylamine N-oxide facilitates the progression of atrial fibrillation in rats with type 2 diabetes by aggravating cardiac inflammation and connexin remodeling.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Connexins; Diabetes Mellitus, Experimental; Diabete | 2022 |
All-Cause Mortality and Trimethylamine N-Oxide Levels in Patients with Cardiovascular Disease.
Topics: Atrial Fibrillation; Biomarkers; Cardiovascular Diseases; Female; Heart Failure; Humans; Male; Methy | 2022 |
GUT MICROBIOTA COMPOSITION AND ITS METABOLITES CHANGES IN PATIENTS WITH ATHEROSCLEROSIS AND ATRIAL FIBRILLATION.
Topics: Atherosclerosis; Atrial Fibrillation; Bacteria; Gastrointestinal Microbiome; Humans | 2022 |
Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients.
Topics: Atrial Fibrillation; Female; Gastrointestinal Microbiome; Humans; Male; Methylamines; Middle Aged; P | 2019 |
Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients.
Topics: Atrial Fibrillation; Data Mining; Gastrointestinal Microbiome; Humans; Methylamines; Oxides | 2020 |
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.
Topics: Aged; Atrial Fibrillation; Betaine; Carnitine; Case-Control Studies; Choline; Female; Heart Failure; | 2021 |
A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Disease Progression; Dogs; Gastrointestinal Microbiome; Heart Atria; I | 2018 |
Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Choline; Female; Follow-Up Studies; Humans; Incidence; Male; Methylamines | 2018 |
Trimethylamine N-oxide: A new therapeutic target for atrial fibrillation?
Topics: Atrial Fibrillation; Humans; Methylamines | 2019 |